Inherited lipid metabolism disorder
MONDO:0002525An inherited metabolic disorder caused by an enzyme deficiency, resulting in an inability to oxidize fatty acids for energy production.
Also known as: disorder of lipid metabolism, dyslipidaemia, dyslipidemia, lipid metabolism disorder, fatty acid metabolism disorder
644 clinical trials for this condition and its sub-types, 201 tagged with Inherited lipid metabolism disorder itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Inherited lipid metabolism disorder
-
Lysosomal lipid storage disorder 2 trials · 192 incl. sub-types
7 sub-types
- Sphingolipidosis 6 trials · 166 incl. sub-types Sub-types →
- Cerebral lipidosis with dementia 0 trials · 38 incl. sub-types Sub-types →
- Neuronal ceroid lipofuscinosis 6 trials · 23 incl. sub-types Sub-types →
- Xanthomatosis 2 trials · 8 incl. sub-types Sub-types →
- Lysosomal acid lipase deficiency 4 trials · 6 incl. sub-types Sub-types →
- Neutral lipid storage disease 1 trial · 2 incl. sub-types Sub-types →
- Triglyceride storage disease 0 trials Sub-types →
-
Familial hyperlipidemia 8 trials · 130 incl. sub-types
10 sub-types
- Familial hypercholesterolemia 58 trials · 94 incl. sub-types Sub-types →
- Hyperlipidemia, familial combined, LPL related 22 trials
- Familial lipoprotein lipase deficiency 6 trials
- Hyperlipoproteinemia type 3 4 trials
- Hyperlipoproteinemia type V 2 trials
- Cholesterol-ester transfer protein deficiency 0 trials
- Familial apolipoprotein C-II deficiency 0 trials
- Hyperlipidemia due to hepatic triglyceride lipase deficiency 0 trials
- Hyperlipidemia, combined, 2 0 trials
- Hyperlipoproteinemia, type 1D 0 trials
-
Syndromic dyslipidemia 0 trials · 73 incl. sub-types
29 sub-types
- CHILD syndrome 37 trials
- Smith-Lemli-Opitz syndrome 6 trials
- Cerebrotendinous xanthomatosis 6 trials
- Familial lipoprotein lipase deficiency 6 trials
- Lysosomal acid lipase deficiency 4 trials · 6 incl. sub-types Sub-types →
- Barth syndrome 5 trials
- Mevalonate kinase deficiency 3 trials · 4 incl. sub-types Sub-types →
- GM1 gangliosidosis type 1 3 trials
- Sjogren-Larsson syndrome 3 trials
- Nephrotic syndrome 14 3 trials
- Apparent mineralocorticoid excess 1 trial
- Neuronal ceroid lipofuscinosis 8 northern epilepsy variant 1 trial
- Peroxisome biogenesis disorder due to PEX5 defect in the PEX7-binding domain 0 trials · 1 incl. sub-types Sub-types →
- Rhizomelic chondrodysplasia punctata type 1 1 trial
- CHIME syndrome 0 trials
- Krabbe disease due to saposin A deficiency 0 trials
- PHARC syndrome 0 trials
- Autosomal recessive complex spastic paraplegia due to kennedy pathway dysfunction 0 trials
- Congenital ichthyosis-intellectual disability-spastic quadriplegia syndrome 0 trials
- Familial apolipoprotein C-II deficiency 0 trials
- Fatty acid hydroxylase-associated neurodegeneration 0 trials
- Hereditary spastic paraplegia 39 0 trials Sub-types →
- Hyperlipoproteinemia, type 1D 0 trials
- Hyperphosphatasia-intellectual disability syndrome 0 trials Sub-types →
- Intellectual disability, autosomal recessive 53 0 trials
- Lipoprotein glomerulopathy 0 trials
- Multiple congenital anomalies-hypotonia-seizures syndrome 2 0 trials
- Sea-blue histiocyte syndrome 0 trials
- Sitosterolemia 0 trials Sub-types →
-
Sterol metabolism disorder 0 trials · 60 incl. sub-types
4 sub-types
- Sterol biosynthesis disorder 0 trials · 45 incl. sub-types Sub-types →
- Cholesterol metabolism disease 3 trials · 13 incl. sub-types Sub-types →
- Inborn disorder of bile acid synthesis 2 trials · 12 incl. sub-types Sub-types →
- Recessive X-linked ichthyosis 2 trials Sub-types →
-
Steroid inherited metabolic disorder 0 trials · 39 incl. sub-types
3 sub-types
- Congenital adrenal hyperplasia 36 trials · 38 incl. sub-types Sub-types →
- Congenital bile acid synthesis defect 1 trial · 2 incl. sub-types Sub-types →
- Apparent mineralocorticoid excess 1 trial
-
Inherited fatty acid metabolism disorder 7 trials · 21 incl. sub-types
3 sub-types
- Disorder of fatty acid oxidation and ketogenesis 1 trial · 16 incl. sub-types Sub-types →
- Carnitine palmitoyl transferase 1A deficiency 1 trial
- Inherited lipoic acid biosynthesis defect 0 trials · 1 incl. sub-types Sub-types →
-
Disorder of phospholipids, sphingolipids and fatty acids biosynthesis 0 trials · 15 incl. sub-types
17 sub-types
- Barth syndrome 5 trials
- Sjogren-Larsson syndrome 3 trials
- Nephrotic syndrome 14 3 trials
- Hereditary sensory and autonomic neuropathy type 1 0 trials · 2 incl. sub-types Sub-types →
- Neutral lipid storage disease 1 trial · 2 incl. sub-types Sub-types →
- 3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome 0 trials
- GM3 synthase deficiency 0 trials
- PHARC syndrome 0 trials
- Sengers syndrome 0 trials
- Autosomal recessive complex spastic paraplegia due to kennedy pathway dysfunction 0 trials
- Congenital ichthyosis-intellectual disability-spastic quadriplegia syndrome 0 trials
- Fatty acid hydroxylase-associated neurodegeneration 0 trials
- Hereditary spastic paraplegia 39 0 trials Sub-types →
- Megaconial type congenital muscular dystrophy 0 trials
- Progressive encephalopathy with leukodystrophy due to DECR deficiency 0 trials
- Progressive myoclonic epilepsy type 8 0 trials
- Spinocerebellar ataxia type 38 0 trials
-
Hypolipoproteinemia 2 trials · 7 incl. sub-types
3 sub-types
- Hypobetalipoproteinemia 2 trials · 3 incl. sub-types Sub-types →
- Norum disease 2 trials
- Tangier disease 0 trials
-
Glucocorticoid resistance 3 trials
-
2 sub-types
-
CYP7B1-related disorder of oxysterol accumulation 0 trials · 2 incl. sub-types
2 sub-types
- Hereditary spastic paraplegia 5A 2 trials
- Congenital bile acid synthesis defect 3 0 trials
-
Disorder of plasmalogens biosynthesis 0 trials · 2 incl. sub-types
5 sub-types
- Rhizomelic chondrodysplasia punctata 2 trials Sub-types →
- Acyl-CoA binding domain containing protein 5 deficiency 1 trial
- Alkylglycerone-phosphate synthase deficiency 0 trials · 1 incl. sub-types Sub-types →
- Glyceronephosphate O-acyltransferase deficiency 0 trials · 1 incl. sub-types Sub-types →
- Fatty acyl-CoA reductase defects 0 trials Sub-types →
-
Inborn disorder of ketolysis 0 trials · 1 incl. sub-types
2 sub-types
-
Cortisone reductase deficiency 0 trials
2 sub-types
- Cortisone reductase deficiency 1 0 trials
- Cortisone reductase deficiency 2 0 trials
-
8 sub-types
- CHIME syndrome 0 trials
- GM3 synthase deficiency 0 trials
- Hypercoagulability syndrome due to glycosylphosphatidylinositol deficiency 0 trials
- Hyperphosphatasia-intellectual disability syndrome 0 trials Sub-types →
- Intellectual disability, autosomal recessive 53 0 trials
- Multiple congenital anomalies-hypotonia-seizures syndrome 1 0 trials
- Multiple congenital anomalies-hypotonia-seizures syndrome 2 0 trials
- Multiple congenital anomalies-hypotonia-seizures syndrome 3 0 trials
-
Lipoid proteinosis 0 trials
-
2 sub-types
- Combined pancreatic lipase-colipase deficiency 0 trials
- Pancreatic colipase deficiency 0 trials
Most studied deeper sub-types
-
Diabetes snack break: golden rice cookies take on bad cholesterol
Disease control CompletedThis study tests whether a cookie made from Golden Rice and red betel leaf can improve cholesterol and triglyceride levels in adults with type 2 diabetes. Over 28 days, 102 participants will eat the cookies daily, and their blood fat levels will be measured before and after. The …
Sponsor: Hasanuddin University • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Ear pellets and statins: a new combo for high cholesterol?
Disease control CompletedThis study tests whether adding ear acupressure (small pellets on specific ear points) to the standard cholesterol drug atorvastatin can lower blood fats and improve phlegm-dampness symptoms better than a sham ear treatment plus atorvastatin. Eighty adults with dyslipidemia and p…
Sponsor: University of Medicine and Pharmacy at Ho Chi Minh City • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
New pill aims to lower 'Bad' cholesterol: first human test begins
Disease control CompletedResearchers are testing a new oral drug called AZD0780 in healthy adults, some with high LDL cholesterol. The Phase 1 trial gives single and multiple rising doses to check safety, side effects, and how the body processes the drug. About 183 volunteers will take either AZD0780 or …
Phase 1 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Can a new injection tame high blood fat?
Disease control CompletedThis trial tests an experimental medicine called NNC0491-6075 for people with high levels of fat in the blood. The main goal is to check whether the medicine is safe and how the body handles it. Healthy volunteers receive a single dose, while people with high blood fat receive we…
Phase 1 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
HIV heart risk targeted: new drug shows promise in reducing arterial inflammation
Disease control CompletedThis study tested whether a drug called alirocumab, which lowers cholesterol, can reduce heart disease risk in people with HIV. The trial involved 118 adults aged 40 and older with well-controlled HIV and high heart disease risk. Participants received either alirocumab or a place…
Phase 3 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Could a common cholesterol drug boost mood treatment?
Disease control CompletedThis study looks at whether taking two approved medicines together—escitalopram for depression and atorvastatin for high cholesterol—can improve both mood and blood fat levels in adults. Participants are adults diagnosed with both a depressive episode and mild-to-moderate dyslipi…
Sponsor: Hengshui City Seventh People's Hospital • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Could vinegar and fasting fix prediabetes cholesterol?
Disease control CompletedThis study tests whether taking date cider vinegar daily, alone or combined with 5:2 intermittent fasting, can improve cholesterol and other metabolic measures in adults with prediabetes and mild to moderate high cholesterol or blood pressure. Participants are randomly assigned t…
Sponsor: University of Lahore • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
New cholesterol drugs enter human testing for first time
Disease control CompletedThis early-stage trial tests two experimental drugs, UI111 and UIC202006, in healthy adult volunteers. The goal is to check the drugs' safety and how the body processes them after a single dose taken with food. The study uses a crossover design, meaning each participant receives …
Phase 1 • Sponsor: Korea United Pharm. Inc. • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Can a smartphone app help lower bad cholesterol?
Disease control CompletedThis trial investigates whether a digital health app called Lipodia can help lower LDL (bad) cholesterol in adults with high cholesterol. Participants either use the app alongside their usual treatment or continue with usual treatment alone. The study measures cholesterol levels …
Sponsor: Gaia AG • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Aerobic exercise may tame multiple chronic conditions in postmenopausal women
Disease control CompletedThis study investigates whether 12 weeks of moderate aerobic exercise can improve heart health, metabolism, and menopause symptoms in postmenopausal women who have two or more chronic conditions like high blood pressure and high cholesterol. Participants will exercise three times…
Sponsor: Federal University of Uberlandia • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Bee product may boost health in oral cancer survivors
Disease control CompletedThis study tests whether a daily dose of Taiwanese Green Propolis, a natural bee-derived supplement, can improve blood fat levels, reduce fatigue, and enhance quality of life in people who have completed treatment for oral cavity cancer. Participants take either propolis capsules…
Sponsor: Taipei Medical University • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
One-Stop health check: can integrated care tame HIV and heart disease together?
Disease control CompletedThis trial tests a package of services called TASKPEN, which combines HIV care with screening and treatment for high blood pressure, diabetes, and tobacco use. It involves over 5,700 adults living with HIV in Lusaka, Zambia. The goal is to see if this integrated approach helps mo…
Sponsor: University of North Carolina, Chapel Hill • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Natural supplement shows promise for borderline high cholesterol
Disease control CompletedThis study tested a dietary supplement made from olive and myrtle extracts in 112 adults with mildly high cholesterol. Participants took either the supplement or a placebo daily for three months while following a controlled diet. The goal was to see if the supplement could help m…
Sponsor: Labomar SPA • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Fatty acid bars show promise for metabolic syndrome
Disease control CompletedThis study tested whether bars made with polyunsaturated fatty acids could improve cholesterol and fat levels in people with metabolic syndrome. 60 adults aged 40-65 with high BMI and abnormal cholesterol took part. The goal was to see if these bars could help control dyslipidemi…
Sponsor: University of Lahore • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Watermelon rind bread shows promise for heart health
Disease control CompletedThis study looked at whether bread made from watermelon rind could improve heart health in 120 adults with mild to moderate heart issues. Participants were between 35 and 65 years old and had conditions like high blood pressure, unhealthy cholesterol levels, or pre-diabetes. The …
Sponsor: University of Lahore • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Vitamin e and fiber combo tested for cholesterol control
Disease control CompletedThis study tested whether taking vitamin E (400 mg daily) alone or together with psyllium husk (10 g daily) for 60 days could improve blood fat levels in adults with high cholesterol and triglycerides. Sixty participants aged 40–60 were randomly assigned to one of three groups: v…
Phase 2 • Sponsor: NUR International University • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New drug shows promise for Long-Term cholesterol control
Disease control CompletedThis study looked at the long-term safety of a drug called ARO-APOC3 in adults with dyslipidemia (abnormal fat levels in the blood). Participants who completed a previous 12-month study could continue receiving the drug every 3 or 6 months. The goal was to see if the drug remains…
Phase 2 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Natural supplement shows promise for fatty liver
Disease control CompletedThis study tested whether taking phytosterols (plant-based supplements) for 3 months can improve liver health, cholesterol, and insulin levels in people with nonalcoholic fatty liver disease (NAFLD). 27 participants took either phytosterol pills or a placebo. Researchers measured…
Sponsor: University of Jordan • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Pecans may help lower cholesterol, new study suggests
Disease control CompletedThis study looked at whether eating different amounts of pecans every day for 28 days can improve cholesterol and other heart health markers in adults who are overweight or have high cholesterol. 108 participants were split into groups that ate pecans providing 6%, 13%, or 20% of…
Sponsor: University of Georgia • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Cottonseed oil: a new Heart-Healthy cooking oil?
Disease control CompletedThis study looked at whether adding small amounts of cottonseed oil to the diet can improve cholesterol and other heart disease risk factors. 95 adults at increased risk for heart disease drank shakes and ate snacks with different amounts of cottonseed oil for 28 days. Researcher…
Sponsor: University of Georgia • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Plant power: natural extract shows promise for high cholesterol
Disease control CompletedThis study tested whether a special extract from plants (phytosterols and phytostanols) can help lower cholesterol levels in adults with high cholesterol. 42 people took either the extract or a placebo for a period of time. The main goal was to see if the extract could reduce tot…
Sponsor: Desirée Victoria Montesinos • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
One pill to tackle two heart risks: triple combo tested
Disease control CompletedThis completed Phase 4 trial tested a single pill containing three medicines (telmisartan, amlodipine, and rosuvastatin) in 252 Korean adults with both high blood pressure and high cholesterol. Participants took either the triple pill or a two-drug pill for 8 weeks. The study mea…
Phase 4 • Sponsor: Hyo-Soo Kim • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Low-Dose statin shows promise for korean heart patients
Disease control CompletedThis study tested a low dose (10 mg) of the statin drug rosuvastatin in 242 Korean adults with high cholesterol or heart disease risk. The goal was to see how much it lowered 'bad' LDL cholesterol after 8 weeks. Results help guide cholesterol treatment in this population.
Sponsor: Seoul National University Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Three months of gym training shows promise for blood sugar control
Disease control CompletedThis study looked at whether a 3-month supervised exercise program can improve blood sugar, body fat, and fitness in sedentary men aged 35-65 with type 2 diabetes, prediabetes, or overweight. Participants exercised at a fitness center under supervision. The goal was to see how di…
Sponsor: Medical University of Bialystok • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Digital program aims to slash heart disease risk by lowering cholesterol
Disease control CompletedThis study tested a digital quality improvement program to help doctors better manage LDL (bad) cholesterol in patients with heart disease. Over 1,400 adults with established cardiovascular disease participated. The program used smartphone tools to improve treatment and follow gu…
Sponsor: Hospital Israelita Albert Einstein • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Soymilk study: could a daily glass cut your cholesterol?
Disease control CompletedThis study tested whether drinking unsweetened soymilk every day can lower cholesterol in adults with high levels. Twenty-five participants drank two bottles (750 mL total) daily for 8 weeks. Researchers measured cholesterol and other health markers to see if the soymilk helped i…
Sponsor: National Taiwan Sport University • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Can a common statin help kids with kidney disease and high cholesterol?
Disease control CompletedThis completed Phase 4 trial tested the drug atorvastatin (Lipitor) in 100 children aged 8-18 with steroid-sensitive nephrotic syndrome and high cholesterol. The goal was to see if the drug safely lowers cholesterol to healthy levels within 3 to 6 months. The study compared atorv…
Phase 4 • Sponsor: National Institute of Kidney Disease and Urology (NIKDU) • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Supplement shows promise for lowering bad cholesterol
Disease control CompletedThis study tested whether a daily dietary supplement could lower LDL (bad) cholesterol in 90 healthy adults with slightly high levels. Participants took either the supplement or a placebo for 12 weeks, along with standard diet advice. The main goal was to see if the supplement re…
Sponsor: Cooper Consumer Health • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Experimental drug targets harmful blood fats in early trial
Disease control CompletedThis early-stage study tested an experimental drug called ALN-APOC3 in 32 adults with dyslipidemia (abnormal blood fat levels). The main goal was to check safety and how the drug affects fat levels in the blood. Participants were otherwise healthy and either not on statins or on …
Phase 1 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Tuna nuggets show promise for heart health
Disease control CompletedThis study tested whether eating tuna-based nuggets for three months could improve health in 120 people with heart disease and related conditions like obesity and diabetes. The nuggets were given as a source of selenium. Results showed improvements in some markers of inflammation…
Sponsor: University of Lahore Hospital (ULH) • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New study tests two ways to improve health in black adults with obesity
Disease control CompletedThis pilot study tested two approaches to improve metabolic health in Black adults with stage 1 obesity and conditions like high blood pressure or prediabetes. Participants received either weight-focused or weight-neutral health coaching for 7 weeks. The goal was to see if a larg…
Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
HIV drug switch may protect hearts: small study tests doravirine
Disease control CompletedThis completed early-phase trial tested whether switching HIV medications to doravirine (with emtricitabine and tenofovir alafenamide) could improve cholesterol and reduce early signs of artery hardening compared to staying on integrase inhibitors. Twenty-six adults with well-con…
Early phase 1 • Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Waltz your way to better cholesterol: study tests dance and resistance combo
Disease control CompletedThis study looked at whether adding elastic band resistance training to waltz dancing could help improve cholesterol levels in women aged 45 to 65 with dyslipidemia (abnormal blood fats). Sixty women participated in a 12-week program of supervised exercise classes three times a w…
Sponsor: Gdansk University of Physical Education and Sport • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New combo pill aims to slash dangerous blood fats in High-Risk patients
Disease control CompletedThis study tested a drug called Cipros 20 in 406 adults with dyslipidemia (abnormal levels of fats in the blood) who also had high or very high heart disease risk. The goal was to see if it lowers triglycerides and LDL cholesterol more effectively than current options. Participan…
Phase 3 • Sponsor: EMS • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New drug aims to tackle two key risks in kidney dialysis patients
Disease control CompletedThis Phase 3 trial tested MCI-196, a drug that binds phosphorus and lowers cholesterol, in 642 adults on dialysis with chronic kidney disease. Participants received either MCI-196 or a placebo for 12 weeks. The goal was to see if the drug could safely reduce both serum phosphorus…
Phase 3 • Sponsor: Tanabe Pharma Corporation • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Two cholesterol drugs better than one? new study investigates
Disease control CompletedThis completed trial looked at whether taking two cholesterol-lowering drugs (rosuvastatin and ezetimibe) is more effective and safer than taking just one (rosuvastatin) for people with heart disease. 66 adults with high cholesterol were randomly assigned to one of the two treatm…
Phase 2/3 • Sponsor: Beni-Suef University • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Cutting red meat from mediterranean diet may slash cholesterol
Disease control CompletedThis study tested whether a Mediterranean diet that removes red and processed meat can lower LDL cholesterol and other heart disease risk factors. 157 adults with high cholesterol were assigned to either the special diet or standard heart-health advice for 8 weeks. Researchers me…
Sponsor: Universidad de Granada • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
New drug aims to lower dangerous fats in the blood
Disease control CompletedThis early-stage study tested a new medicine called ARO-ANG3 in 93 people, including healthy volunteers and patients with high cholesterol or high triglycerides. The main goal was to check if the drug is safe and how the body processes it. This research helps determine if the dru…
Phase 1 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
New Statin-CBD combo drug enters first human safety trial
Disease control CompletedThis early-stage study tested the safety of Atorvo+™, a new drug that combines the common cholesterol-lowering medication atorvastatin with cannabidiol (CBD). The trial involved 24 healthy adults aged 40-75 to see how the body processes the drug and if it causes any side effects.…
Phase 1 • Sponsor: Indication Bioscience LLC • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Can a daily supplement blend curb cravings and improve cholesterol?
Disease control CompletedThis study tested whether a daily combination of commercially available food supplements could help overweight adults over 45 feel fuller and improve their cholesterol and blood sugar levels. Eighty participants were split into two groups: one took the supplement mix for 12 weeks…
Sponsor: University of Alicante • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
New combo drug aims to tackle high cholesterol in one daily pill
Disease control CompletedThis Phase 3 trial tested a new combination drug called Cipros 10 against the standard statin Crestor in 146 adults with dyslipidemia (high cholesterol and triglycerides). The goal was to see if Cipros 10 could lower triglyceride levels more effectively. Participants took one pil…
Phase 3 • Sponsor: EMS • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
New Once-Daily pill aims to lower high triglycerides
Disease control CompletedThis study tested a new extended-release form of pemafibrate (K-877) in 121 adults with high triglycerides, a type of fat in the blood. Participants took the drug once daily for 52 weeks, either in the morning or evening, to see if it safely lowers triglyceride levels and improve…
Phase 3 • Sponsor: Kowa Company, Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New Cholesterol-Lowering pill shows promise in Mid-Stage trial
Disease control CompletedThis study tested a new daily medication called AZD0780 in 428 adults with dyslipidemia (abnormal cholesterol levels). Participants took one of several doses of AZD0780 or a placebo for 12 weeks. The main goal was to see how much the drug lowered LDL (bad) cholesterol compared to…
Phase 2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
New cholesterol combo drug shows promise in early trial
Disease control CompletedThis early-stage study tested a new drug called AZD0780 in 81 healthy adults with high cholesterol. Participants received AZD0780 alongside other cholesterol-lowering medicines like ezetimibe, rosuvastatin, or bempedoic acid. The goal was to see how well the combination lowers LD…
Phase 1 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Community health workers lead push to cut heart disease in pasifika communities
Disease control CompletedThis study tested a 3-month lifestyle program, delivered by Pasifika community health workers, to help Native Hawaiians and Pacific Islanders with conditions like diabetes, high blood pressure, and obesity. The program included healthy eating and activity tips plus support for so…
Sponsor: University of Hawaii • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
New pill for high cholesterol shows promise in early trial
Disease control CompletedThis study tested a new controlled-release version of the drug pemafibrate in 60 adults with dyslipidemia (abnormal levels of fats in the blood). The goal was to see if the new version works as well or better than the current immediate-release tablet, with fewer side effects. Par…
Phase 2 • Sponsor: Kowa Company, Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
New daily pill aims to crush stubborn cholesterol in High-Risk patients
Disease control CompletedThis Phase 3 trial tested a daily pill combining two drugs, obicetrapib and ezetimibe, in 407 people with inherited high cholesterol or heart disease. Participants took the combination or a placebo on top of their usual cholesterol meds. The main goal was to see if the combo lowe…
Phase 3 • Sponsor: NewAmsterdam Pharma • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New pill could help lower stubborn high cholesterol
Disease control CompletedThis study tested a new drug called obicetrapib in over 2,500 people with high cholesterol that wasn't well controlled by their current treatments. Participants took either a 10 mg obicetrapib pill or a placebo daily for about 6 months. The main goal was to see if obicetrapib cou…
Phase 3 • Sponsor: NewAmsterdam Pharma • Aim: Disease control
Last updated Jun 26, 2026 18:50 UTC
-
Fish oil and exercise: a One-Two punch against obesity inflammation?
Disease control CompletedThis study looked at whether taking fish oil and doing high-intensity interval training (HIIT) could lower inflammation in people who are overweight or obese. Researchers measured changes in blood markers of inflammation and metabolism over 10 weeks. The goal was to see if the co…
Sponsor: Texas Tech University • Aim: Disease control
Last updated Jun 26, 2026 16:24 UTC
-
New cholesterol drug VSA003 passes first safety test in healthy volunteers
Disease control CompletedThis early-phase study tested a single dose of VSA003 in 36 healthy Chinese adults to see if it is safe and how the body handles it. The drug aims to help control high cholesterol and triglycerides. Participants received either VSA003 or a placebo, and researchers monitored for s…
Phase 1 • Sponsor: Visirna Therapeutics HK Limited • Aim: Disease control
Last updated Jun 26, 2026 15:39 UTC
-
New combo pill aims to lower cholesterol in phase 3 trial
Disease control CompletedThis completed Phase 3 trial tested a combination of two drugs, JW0108 and C2407, in 145 adults with high cholesterol (dyslipidemia). The goal was to see if the combo lowers LDL ('bad') cholesterol more effectively and safely than placebo. Researchers measured changes in LDL leve…
Phase 3 • Sponsor: JW Pharmaceutical • Aim: Disease control
Last updated Jun 26, 2026 13:22 UTC
-
Emergency room visit could be a turning point for metabolic health
Prevention CompletedThis pilot trial tests whether a multi-part program given to emergency department patients with metabolic syndrome can encourage more walking and healthier habits. Participants receive a Fitbit, watch a short educational video, get a written exercise prescription, receive text re…
Sponsor: Indiana University • Aim: Prevention
Last updated Aug 21, 2026 00:00 UTC
-
Vitamin B3 supplement put to the test against psoriasis inflammation
Symptom relief CompletedResearchers are testing whether nicotinamide riboside, a form of vitamin B3 sold as a supplement, can reduce immune system activation in people with mild to moderate psoriasis. The trial enrolls adults aged 18 to 80 who are not on biologic therapy. Participants take either the su…
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Symptom relief
Last updated Sep 11, 2026 00:00 UTC
-
Smoking and diet may shape cholesterol in mexican adults
Knowledge-focused CompletedResearchers are studying how traditional and non-traditional heart risk factors relate to cholesterol levels in hospitalized Mexican adults. The study focuses on HDL cholesterol, often called good cholesterol, and how it behaves in people who smoke or have certain dietary habits.…
Sponsor: Hospital General de Chihuahua - Dr. Salvador Zubirán Anchondo • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Healthy volunteers to test if two cholesterol meds are identical
Knowledge-focused CompletedThis study checks if a new version of a cholesterol-lowering drug (AJU-C715) works the same as the original (C715R) in 60 healthy adults aged 19-59. Participants take a single dose of each drug in random order and have blood tests to compare drug levels. The goal is to see if the…
Phase 1 • Sponsor: AJU Pharm Co., Ltd. • Aim: Knowledge-focused
Last updated Sep 11, 2026 00:00 UTC
-
Scientists probe fat particles to unlock heart disease secrets
Knowledge-focused CompletedThis study looked at how fat-carrying particles called lipoproteins work in healthy people and those with high cholesterol or other lipid disorders. Researchers injected tiny, safe amounts of radioactive lipoproteins to track them in the body. The goal was to better understand ho…
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Sep 10, 2026 00:00 UTC
-
Gene hunt for rare cholesterol problems
Knowledge-focused CompletedThis study aimed to find new gene changes that cause rare lipid disorders. Researchers used advanced genetic testing to look at many genes at once in 140 people and their relatives. The goal was to discover causes that older methods missed.
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Aug 30, 2026 00:00 UTC
-
STREAM trial: should seniors ditch statins?
Knowledge-focused CompletedThis study looks at whether adults aged 70 and older with multiple chronic conditions (but no heart disease) can safely stop taking statins. Researchers are comparing those who continue statins to those who stop, tracking deaths and major heart events over 2-4 years. The goal is …
Sponsor: Insel Gruppe AG, University Hospital Bern • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC
-
Fake health news: study reveals how online lies harm chronic patients
Knowledge-focused CompletedThis study looks at how false or misleading health information found online affects the way people with chronic illnesses like diabetes and high blood pressure take their medications and make treatment decisions. Researchers will survey 300 adults who use social media at least on…
Sponsor: Alexandria University • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC
-
Army launches major health check on 600 soldiers
Knowledge-focused CompletedThis study will assess the diet, heart health, body composition, mental wellbeing, and physical performance of 600 U.S. Army soldiers. Researchers aim to gather detailed data on nutrition and health, similar to a national survey but tailored for the military. The goal is to bette…
Sponsor: Pennington Biomedical Research Center • Aim: Knowledge-focused
Last updated Jul 19, 2026 00:00 UTC
-
New cholesterol drug candidate tested in healthy volunteers
Knowledge-focused CompletedThis early-stage trial tests a new drug called AJU-C716 against a reference drug (C716R) in 41 healthy adults aged 19 to 55. The goal is to see how safe the drug is and how the body processes it. This study does not test if the drug works for high cholesterol—it only looks at saf…
Phase 1 • Sponsor: AJU Pharm Co., Ltd. • Aim: Knowledge-focused
Last updated Jul 12, 2026 00:00 UTC
-
Could AI help pharmacists give better advice?
Knowledge-focused CompletedThis study tests whether pharmacists using a generative AI tool (ChatGPT) can provide more accurate and complete medication counseling compared to standard practice. The trial involves 136 adults with chronic conditions like diabetes, high blood pressure, or asthma who are pickin…
Sponsor: University of Petra • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Scientists probe hidden link between blood protein and heart disease
Knowledge-focused CompletedThis study looked at 99 people with high heart risk to understand how a protein called CETP affects plaque buildup in arteries. Researchers measured CETP activity, artery thickness, and calcium scores. The goal was to learn more about heart disease, not to test a new treatment.
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
New drug HRS-5632 tested in healthy people for safety
Knowledge-focused CompletedThis early-stage study tested a single injection of HRS-5632 in 50 healthy adults to check its safety and how the body processes it. Participants were aged 18 to 55 and in good health. The study did not aim to treat any disease, only to gather initial safety information.
Phase 1 • Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:04 UTC
-
Scientists dig into Cholesterol's hidden secrets to fight heart disease
Knowledge-focused CompletedThis study looked at 86 people with very high or very low cholesterol efflux—a measure of how well the body removes cholesterol from cells. Researchers analyzed their genes, proteins, and lipids to find clues that could lead to new ways to prevent or reverse heart disease. The go…
Sponsor: University of Texas Southwestern Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:04 UTC
-
Do statins block exercise benefits? new study investigates
Knowledge-focused CompletedThis study looked at how taking statins (a common cholesterol-lowering drug) along with a structured exercise program affects muscle cells and overall fitness in adults aged 40-65 with high cholesterol. 120 participants were split into four groups: exercise plus placebo, exercise…
Sponsor: University of the Faroe Islands • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:07 UTC
-
Scientists investigate why high 'Bad' cholesterol harms heart repair cells
Knowledge-focused CompletedThis completed study examined blood samples from 40 adults to see if high levels of lipoprotein (a), a type of cholesterol, are linked to fewer or different blood vessel repair cells. Participants with high Lp(a) were compared to those with normal levels. The goal was to better u…
Sponsor: Canadian Medical and Surgical Knowledge Translation Research Group • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC
-
Can a tailored diet and exercise program help with insulin resistance? small study tests feasibility
Knowledge-focused CompletedThis study tested whether a personalized lifestyle program could be run in a family medicine clinic for people with insulin resistance and related conditions like obesity, diabetes, and high blood pressure. Forty participants were randomly assigned to start with either nutrition …
Sponsor: University of Alabama at Birmingham • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:53 UTC
-
New strategy aims to help mental health staff better manage heart risks
Knowledge-focused CompletedThis pilot study tested a quality improvement process called CUSP to help community mental health staff deliver better care for cardiovascular risk factors like high blood pressure, diabetes, and high cholesterol. The study included 85 staff and patients from psychiatric rehabili…
Sponsor: Johns Hopkins University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC